DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Triptorelin
Triptorelin
Hertfordshire Medicines Management Committee (Hmmc) Nafarelin for Endometriosis Amber Initiation – Recommended for Restricted Use
Degarelix for Treating Advanced Hormone- Dependent Prostate Cancer
The Use of an Intravaginal Triptorelin Gel to Induce Ovulation in the Mare
Triptorelin, Goserelin and Leuprorelin for Prostate
Comparison of Oocyte Maturity Rates in Recombinant Human Chorionic Go
Triptodur (Triptorelin)
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal
Recent Development of Non-Peptide Gnrh Antagonists
A Randomised Controlled Trial to Determine the Effect of Triptorelin on Reduction of Prostate Volume Pre- Radiotherapy Compared with Standard Therapy (Goserelin)
Effects of an Extended-Interval Dosing Regimen of Triptorelin Depot on the Hormonal Profile of Patients with Endometriosis: Prospective Observational Study
Prostate Cancer: Triptorelin (Decapeptyl SR)
The Effects of Different Gonadotropin Releasing Hormone Analogues in IVF Cycles
Triptodur™ (Triptorelin) – New Drug Approval
D Rug U Tilization R Eview B Oard
Trelstar LA 11.25Mg for Injectable Suspension Triptorelin Pamoate for Injectable Suspension
Trelstar® (Triptorelin)
Appendix B - Product Name Sorted by Applicant
Gonadotropin-Releasing Hormone Agonists
Top View
Clinical Policy: Triptorelin Pamoate (Trelstar, Triptodur) Reference Number: ERX.SPA.45 Effective Date: 07.01.16 Last Review Date: 11.17 Revision Log
The Role of Gonadotropin-Releasing Hormone (Gnrh) in Endometrial Cancer
PRODUCT INFORMATION Triptorelin Item No
Comparison of Oocyte Maturity Rates in Recombinant Human Chorionic Gonadotropin (HCG) and Triptorelin Acetate Triggers: a Prospective Randomized Study
RX.PA.012.MPC Revision Date: 02/2020 Page Number 1 of 7
Triptorelin Pamoate (Trelstar) Reference Number: ERX.SPMN.99 Effective Date: 07/16 Revision Log Last Review Date: 06/16
Role of Gonadotropin-Releasing Hormone (Gnrh) in Ovarian Cancer
Confidential and Proprietary, © 2018 Unitedhealthcare Services Inc
The Effects of Cetrorelix and Triptorelin on the Viability and Steroidogenesis of Cultured Human Granulosa Luteinized Cells
Gonadotropin-Releasing Hormone (Gnrh) Analogues in Prostate Cancer
Comparison of Assisted Reproductive Technology Cycle Outcomes
Gonadorelin Analogues for Endometriosis
Gonadotropin-Releasing Hormone Analogs - Firmagon® (Degarelix for Subcutaneous Injection)
Therapeutic Class Overview Gonadotropin-Releasing Hormone (Gnrh) Agonists/ Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
Actions of Gonadotropin-Releasing Hormone Antagonists On
Triptorelin Pamoate (Trelstar) Reference Number: PA.CP.PHAR.175 Effective Date: 01/18 Last Review Date: 02/17 Revision Log
Clinical Utility of Elagolix As an Oral Treatment for Women with Uterine Fibroids: a Short Report on the Emerging Efficacy Data
Gonadorelin Analogues Prescribing Support Information
Clinical Criteria
Efficacy of Elagolix in the Treatment of Endometriosis
Pharmacology Review(S)
Comparative Analysis of Different Puberty Inhibiting Mechanisms of Two Gnrh Agonists and the Gnrh Antagonist Cetrorelix Using a Female Rat Model
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: an Evidence Review Group Perspective of a NICE Single Technology Appraisal
Application of a Multiscale Physiologically-Based Bone And
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer
Gonadotropin Releasing Hormone Analogs
Trelstar® (Triptorelin)
GONADOTROPIN-RELEASING HORMONES Firmagon (Degarelix
The Human Chorionic Gonadotropin Test Is More Powerful Than The
Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
Leuprolide Vs Triptorelin: the Recent Trends in Gnrh Analogues in Precocious Puberty
Effectiveness of Three Different Luteinizing Hormone-Releasing Hormone Agonists in the Chemical Castration of Patients with Pros
Use of a Long-Acting Gonadotrophin-Releasing Hormone Analogue in a Postmenopausal Woman with Hyperandrogenism Due to a Hilus Cell Tumour
LHRH Agonists and Antagonist
Current and Prospective Treatment of Adenomyosis
Gonadotropin-Releasing Hormone Agonists- Eligard®, Fensolvi® (Leuprolide Acetate), Lupron®, Lupron- Depot®, Lupron Depot - Pe D® , Lupaneta® (Leuprolide
Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Pubert
SYNAREL® (Nafarelin Acetate) Nasal Solution
Description Clinical Pharmacology
Pituitary and Gonadal Effects of Gnrh (Gonadotropin Releasing Hormone) Analogues in Two Peripubertal Female Rat Models
Gnrh Modulators TCO 02.2019
Dual Trigger of Triptorelin and HCG Optimizes Clinical Outcome for High Ovarian Responder in Gnrh-Antagonist Protocols
New 0Ral Gonadotropin-Releasing Hormone (Gnrh) Antagonist
Gonadotropin Releasing Hormone Analogs – Commercial Medical Benefit Drug Policy
Ryeqo, INN: Relugolix / Estradiol / Norethisterone Acetate